Can Daily Vitamin D Supplementation Reduce Upper Respiratory Infections in elderly?

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-02-17 06:00 GMT   |   Update On 2024-02-17 10:06 GMT

Vitamin D deficiency has been associated with increased susceptibility to respiratory infections. Daily supplementation has been proposed as a potential intervention to reduce this risk, but the evidence remains uncertain. Recent research has suggested that daily vitamin D supplementation might reduce the risk of acute respiratory infections among individuals with vitamin D deficiency....

Login or Register to read the full article

Vitamin D deficiency has been associated with increased susceptibility to respiratory infections. Daily supplementation has been proposed as a potential intervention to reduce this risk, but the evidence remains uncertain. Recent research has suggested that daily vitamin D supplementation might reduce the risk of acute respiratory infections among individuals with vitamin D deficiency. However, the results of trials investigating this effect in various populations and using different regimens have been inconclusive.

This study was published in the journal of Clinical Infectious Diseases by Carlos A. and colleagues. In this context, the VITamin D and OmegA-3 TriaL (VITAL) sought to determine the impact of daily vitamin D supplementation on the risk of upper respiratory infection (URI) in older adults. The VITAL trial was a randomized, double-blind, placebo-controlled study involving 15,804 older adults (mean age 68 years) with baseline serum total 25-hydroxyvitamin D levels. Participants were randomized to receive either vitamin D3 (2000 IU/day) or placebo. The primary outcome was self-reported recent URI at 1-year follow-up.

The key findings of the study were:

• Mean baseline serum 25-hydroxyvitamin D level: 31 ng/mL, with <12 ng/mL in 2.4%.

• Overall effect of vitamin D supplementation on recent URI: nonsignificant (odds ratio [OR], 0.96; 95% confidence interval [CI], 0.86–1.06).

• In the subgroup with baseline levels <12 ng/mL and no concurrent vitamin D intake, vitamin D supplementation was also nonsignificant (OR, 0.60; 95% CI, 0.28–1.30).

• Limited statistical power to assess effect modification in other subgroups.

Among older adults not specifically selected for vitamin D deficiency, daily vitamin D supplementation did not significantly reduce the risk of URI. Further research is needed to determine if different subgroups may experience varying effects from vitamin D supplementation.

Reference:

Camargo, C. A., Jr, Schaumberg, D. A., Friedenberg, G., Dushkes, R., Glynn, R. J., Gold, D. R., Mora, S., Lee, I. M., Buring, J. E., & Manson, J. E. Effect of daily vitamin D supplementation on risk of upper respiratory infection in older adults: A randomized controlled trial. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America,2023 ciad770. https://doi.org/10.1093/cid/ciad770


Tags:    
Article Source : Clinical Infectious Diseases

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News